NEW YORK (GenomeWeb) – Oxford Genetics said today that it has signed a worldwide distribution agreement with CLS Cell Lines Service to combine CLS's cell lines with Oxford's current menu of bio-therapeutic research products and services.

The agreement gives Oxford's customers access to over 400 mammalian cell lines which can be used in the firm's custom cell line engineering and development services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.